Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIRIUS: Mepolizumab Steroid-Sparing Study in Severe Asthma
NCT01691508Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2012
- Primary completion
- Dec 2013
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 3 trial of mepolizumab in asthma, sponsored by GSK. Started Oct 2012; status: completed.
02
Drugs
mepolizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01691508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691508.